Dougados M - Search Results

1

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group. Baeten D, et al. Among authors: dougados m. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066. N Engl J Med. 2015. PMID: 26699169 Free article. Clinical Trial.

2

Evaluation of a functional index and an articular index in ankylosing spondylitis.

Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Dougados M, et al. J Rheumatol. 1988 Feb;15(2):302-7. J Rheumatol. 1988. PMID: 3283358 Clinical Trial.

3

Management of refractory ankylosing spondylitis and related spondyloarthropathies.

Amor B, Dougados M, Khan MA. Amor B, et al. Among authors: dougados m. Rheum Dis Clin North Am. 1995 Feb;21(1):117-28. Rheum Dis Clin North Am. 1995. PMID: 7732163 Review.

4

Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study.

Dougados M, Nguyen M, Caporal R, Legeais J, Bouxin-Sauzet A, Pellegri-Guegnault B, Gomeni C. Dougados M, et al. Scand J Rheumatol. 1994;23(5):243-8. doi: 10.3109/03009749409103723. Scand J Rheumatol. 1994. PMID: 7973477 Clinical Trial.

5

Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis.

Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E, Calin A. Dougados M, et al. J Rheumatol. 1999 Apr;26(4):971-4. J Rheumatol. 1999. PMID: 10229430 Clinical Trial.

6

Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.

Dougados M, Gueguen A, Nakache JP, Velicitat P, Veys EM, Zeidler H, Calin A. Dougados M, et al. Rheumatology (Oxford). 1999 Mar;38(3):235-44. doi: 10.1093/rheumatology/38.3.235. Rheumatology (Oxford). 1999. PMID: 10325662 Clinical Trial.

7

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Calin A, et al. Among authors: dougados m. Rheumatology (Oxford). 1999 Sep;38(9):878-82. doi: 10.1093/rheumatology/38.9.878. Rheumatology (Oxford). 1999. PMID: 10515650 Clinical Trial.

8

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.

Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H. Dougados M, et al. Arthritis Rheum. 2001 Jan;44(1):180-5. doi: 10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K. Arthritis Rheum. 2001. PMID: 11212158 Free article. Clinical Trial.

9

[Ankylosing spondylitis].

Dougados M. Dougados M. Rev Prat. 2001 Nov 1;51(17):1961-7. Rev Prat. 2001. PMID: 11787231 French. No abstract available.

10

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.

Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Emery P, et al. Among authors: dougados m. Ann Rheum Dis. 2002 Apr;61(4):290-7. doi: 10.1136/ard.61.4.290. Ann Rheum Dis. 2002. PMID: 11874828 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,120 results

Search Page